CYTK Cytokinetics
- 51.940
- -0.840-1.59%
- 52.104
- +0.164+0.32%
Cytokinetics News
Insider Selling: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
Cytokinetics(CYTK.US) Director Sells US$262.75K in Common Stock
$Cytokinetics(CYTK.US)$ Director PARSHALL B LYNNE sold 5,000 shares of common stock on Jun 17, 2024 at an average price of $52.55 for a total value of $262.75K.Source: Announcement What is statement o
Cytokinetics(CYTK.US) Officer Sells US$1.18 Million in Common Stock
$Cytokinetics(CYTK.US)$ Officer Blum Robert I sold 22,500 shares of common stock on Jun 17, 2024 at an average price of $52.6 for a total value of $1.18 million.Source: Announcement What is statement
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 1.18 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $Cytokinetics(CYTK.US)$ Officer ROBERT BLUM intends to sell 22,500 shares of its common stock on Jun 17, with a total market value of approximately $1.18 million. ROB
Cytokinetics Insider Sold Shares Worth $1,183,391, According to a Recent SEC Filing
Robert I Blum, Director, President & CEO, on June 17, 2024, sold 22,500 shares in Cytokinetics (CYTK) for $1,183,391. Following the Form 4 filing with the SEC, Blum has control over a total of 420,811
Form 144 | Cytokinetics(CYTK.US) Director Proposes to Sell 262.73K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $Cytokinetics(CYTK.US)$ Director B LYNNE PARSHALL intends to sell 5,000 shares of its common stock on Jun 17, with a total market value of approximately $262.73K. B L
H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $90
H.C. Wainwright analyst Joseph Pantginis maintains $Cytokinetics(CYTK.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 0.0% a
HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $90 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $90 price target.
Cytokinetics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/17/2024 70.2% HC Wainwright & Co. $90 → $90 Reiterates Buy → Buy 06/04/2024 73.98% B. Riley Securities
Express News | Cytokinetics Has Dosed The First Participants In A Phase 1 Study Evaluating The Pharmacokinetics, Safety And Tolerability Of Aficamten In Healthy Japanese And Caucasian Participants
Express News | Cytokinetics Inc: Expects Marketing Authorization Application (Maa) to European Medicines Agency (EMA) in Q4 2024
Express News | Cytokinetics Expects Nda Submission to FDA in Q3 2024
Express News | Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
Insider Sale at Cytokinetics Inc (CYTK) by EVP of Research & Development
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 413.12K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 11, $Cytokinetics(CYTK.US)$ Officer FADY MALIK intends to sell 7,788 shares of its common stock on Jun 11, with a total market value of approximately $413.12K. FADY MALIK
Cytokinetics(CYTK.US) Officer Sells US$413.11K in Common Stock
$Cytokinetics(CYTK.US)$ Officer Malik Fady Ibraham sold 7,788 shares of common stock on Jun 11, 2024 at an average price of $53.04 for a total value of $413.11K.Source: Announcement What is statement
Cytokinetics Insider Sold Shares Worth $413,106, According to a Recent SEC Filing
Fady Ibraham Malik, Executive Vice President, Research & Development, on June 11, 2024, sold 7,788 shares in Cytokinetics (CYTK) for $413,106. Following the Form 4 filing with the SEC, Malik has contr
Insider Sale: Director Muna Bhanji Sells Shares of Cytokinetics Inc (CYTK)
Form 144 | Cytokinetics(CYTK.US) Director Proposes to Sell 104.14K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 10, $Cytokinetics(CYTK.US)$ Director MUNA BHANJI intends to sell 2,000 shares of its common stock on Jun 10, with a total market value of approximately $104.14K. Source:
Cytokinetics(CYTK.US) Director Sells US$104.14K in Common Stock
$Cytokinetics(CYTK.US)$ Director Bhanji Muna sold 2,000 shares of common stock on Jun 10, 2024 at an average price of $52.07 for a total value of $104.14K.Source: Announcement What is statement of cha
Analysis
Price Target
No Data
